Sorafenib
Drug Details
- Description
- Sorafenib is an oral multi-kinase inhibitor used to treat certain types of cancer, including advanced renal cell carcinoma, unresectable hepatocellular carcinoma, and radioactive iodine-resistant thyroid carcinoma. It works by inhibiting tumor cell proliferation and angiogenesis.
- Alternative Names
- Sorafenib.
- Key Genes
- Key genes associated with sorafenib include RAF1, BRAF, VEGFR, PDGFR, and KIT.
- Drug Use
- Sorafenib is used to treat advanced kidney cancer (renal cell carcinoma), liver cancer (hepatocellular carcinoma), and a type of thyroid cancer called differentiated thyroid carcinoma.
- Genetic Factors Influencing Response
-
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Purchase Membership to Access Your Individual Drug Response Report